Inventor · disambiguated record
Jonathan Wright
Also filed as: WRIGHT JONATHAN · WRIGHT JONATHAN L
15 granted patents·3 pending applications·298 citations·filing 1992–2009
94Inventor score
Files withWARNER LAMBERT CO9SIGNAL PHARM LLC5ALBERS RONALD J1D SIDOCKY NEIL R1SIGNAL PHARMACEUTICAL LLC1
Top patents by PatentIndex Score
18 records- 0195US7723340B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2006·Granted May 25, 2010·46 cites·51 claims
- 0294US7521446B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2006·Granted Apr 21, 2009·39 cites·60 claims
- 0388US8101588B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithALBERS RONALD J·Filed 2009·Granted Jan 24, 2012·22 cites·29 claims
- 0485US5552411ASulfonylquinolines as central nervous system and cardiovascular agentsWARNER LAMBERT CO·Filed 1995·Granted Sep 3, 1996·38 cites·10 claims
- 0582US5395835ANaphthalamides as central nervous system agentsWARNER LAMBERT CO·Filed 1994·Granted Mar 7, 1995·51 cites·6 claims
- 0679US6284774B14-Benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonistsWARNER LAMBERT CO·Filed 1999·Granted Sep 4, 2001·46 cites·28 claims
- 0777US7358274B2Methods for treating or preventing cancer using Benzopyranone CompoundsSIGNAL PHARM LLC·Filed 2006·Granted Apr 15, 2008·2 cites·11 claims
- 0875US6448270B14-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonistsWARNER LAMBERT CO·Filed 2000·Granted Sep 10, 2002·6 cites·17 claims
- 0973US7091235B2Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancerSIGNAL PHARM LLC·Filed 2003·Granted Aug 15, 2006·5 cites·11 claims
- 1067US6130234A4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonistsWARNER LAMBERT CO·Filed 1996·Granted Oct 10, 2000·17 cites·16 claims
- 1161US7589119B2Methods for treating or preventing metastatic cancer using benzopyranone compoundsSIGNAL PHARMACEUTICAL LLC·Filed 2008·Granted Sep 15, 2009·0 cites·14 claims
- 1261US5414010ADimeric benzimidazoles as central nervous system agentsWARNER LAMBERT CO·Filed 1994·Granted May 9, 1995·7 cites·5 claims
- 1360US2009312320A1Methods of treatment comprising the administration of haloaryl substituted aminopurines or compositions thereofSIGNAL PHARM LLC·Filed 2009·Application pending·0 cites
- 1454US5314896A1,3-substituted cycloalkenes and cycloalkanes as central nervous system agentsWARNER LAMBERT CO·Filed 1992·Granted May 24, 1994·9 cites·7 claims
- 1552US2003105133A14-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonistsFiled 2002·Application pending·0 cites
- 1650US5409931A1,3-substituted cycloalkenes and cycloalkanes as central nervous system agentsWARNER LAMBERT CO·Filed 1994·Granted Apr 25, 1995·7 cites·6 claims
- 1749US5486517ABenzimidazoles and imidazopyridines as central nervous system agentsWARNER LAMBERT CO·Filed 1994·Granted Jan 23, 1996·3 cites·5 claims
- 1846US2008242694A1Amino-substituted heterocycles, compositions thereof, and methods of treatment therewithD SIDOCKY NEIL R·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Wright files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →